Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

Our DNA is constantly under threat — from cell division errors to external factors like sunlight and smoking. Fortunately, ...

A new study from Memorial Sloan Kettering Cancer Center has shown that an RNA-based neoantigen vaccine can generate ...

For the Liu Lab, necessity is truly the mother of invention. The researchers were examining how the 3D organization of the ...

This listicle explores four major RNA therapeutic modalities, highlighting their breakthroughs, challenges and future ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

One famous experiment conducted in 1952 by American chemists Stanley Miller and Harold Urey provided a possible explanation: ...

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

The RNA inhibitor reduces levels of oxidized phospholipids, which are presumed to promote atherosclerosis, by more than 93%.

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

As we continue to advance our Axiomer ADAR-mediated RNA editing platform and pipeline, ProQR is entering a pivotal phase of growth and ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Ono Pharmaceutical Co., Ltd (Ono), today announced that the two companies have ...